Imunon, Inc. (IMNN)

NASDAQ: IMNN · USD

$0.87

-0.01 (-1.1%)· Recorded snapshot

Market cap	4.9M
Net income (ttm)	-14.7M
EPS (ttm)	-$3.57
Shares out	5.6M
Volume	188,036
Beta	2.01

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -14.7M
EPS (ttm): -$3.57
Market cap: 4.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Conserver

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-429.7

P25 -113.8P50 -46.5P75 -0.9

ROIC-116.7

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All IMNN indicators

Market & fundamental data

Available fields

190

Groups with data

Currency

USD

Showing 190 of 190 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000749647
Company name	Imunon, Inc.
Country	United States
Country code	US
CUSIP number	15117N701
Earnings date	2026-11-12
Earnings time	bmo
Employees	20
Employees change	-5
Employees growth	-20%
Enterprise value	$5.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1982
Industry	Biotechnology
IPO date	1985-03-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US15117N7012
Last 10-K release date	2026-03-31
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split date	2025-08-07
Last stock split type	Forward
Market cap	$4.9M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$0.87
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	IMNN
U.S. state	New Jersey
Website	https://imunon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-411.75%
FCF / EV yield	-257.42%
FCF yield	-308.77%
P/B ratio	2.11x
Price / tangible book value	2.54x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-736,658
ROA	-77.99%
ROA (5Y)	-49.73%
ROCE	-145.3%
ROE	-429.72%
ROE (5Y)	-139.83%
ROIC	-116.73%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	14
EPS growth years	3
Net income growth years	3
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-72,669
Depreciation and amortization	$290,218
EBIT	$-14.8M
EBITDA	$-14.5M
EPS	$-3.57
FCF per share	$-2.71
Financing cash flow	$22.3M
Free cash flow	$-15.2M
Free cash flow minus SBC	$-16.2M
Gross profit	$-409,917
Investing cash flow	$-72,669
Net borrowing	$7M
Net cash flow	$7.1M
Net income	$-14.7M
Operating cash flow minus SBC	$-16.1M
Operating income	$-14.8M
Stock-based compensation	$996,462

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$0.42
Debt / equity	1.87
Interest coverage	-191.99
Long-term assets	$6.3M
Long-term liabilities	$6M
Net cash (debt)	$-980,914
Net cash / market cap	-19.95%
Net debt / equity	0.23
Piotroski F-Score	1
Property, plant and equipment	$1.2M
Shareholders' equity	$4.2M
Tangible book value	$1.9M
Tangible book value per share	$0.42
Total assets	$15M
Total cash	$6.9M
Total debt	$7.8M
Total liabilities	$10.8M
WACC	6.37%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$8.7M
Current liabilities	$4.8M
Current ratio	1.82
Net working capital	$-1M
Quick ratio	1.44
Working capital	$3.9M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-217.32%
Dividend yield	0%
Shareholder yield	-217.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-99.97%
10Y return CAGR	-55.68%
10Y total return	-99.97%
150-day SMA	$1.93
15Y price change	-100%
15Y return CAGR	-50.75%
15Y total return	-100%
1D price change	-1.07%
1M price change	-38.52%
1M total return	-38.52%
1W price change	-27.16%
1W total return	-27.16%
1Y price change	-81.64%
1Y return CAGR	-81.66%
1Y total return	-81.64%
20-day SMA	$1.11
200-day SMA	$2.26
20Y price change	-100%
20Y return CAGR	-41.06%
20Y total return	-100%
3M price change	-43.35%
3M total return	-43.35%
3Y price change	-93.29%
3Y return CAGR	-59.35%
3Y total return	-93.29%
50-day SMA	$1.34
50-day SMA vs 200-day SMA	50under200
52-week high	$4.90
52-week high date	2025-10-28
52-week low	$0.83
52-week low date	2026-10-27
5Y price change	-99.5%
5Y return CAGR	-65.41%
5Y total return	-99.5%
6M price change	-69.04%
6M total return	-69.04%
All-time high	$1,895,059.90
All-time high date	2000-03-03
All-time low	$0.83
All-time low date	2026-10-27
Average true range (ATR)	$0.11
Average volume	115.9K
Beta (1Y)	1.24
Beta (2Y)	-0.96
Beta (5Y)	2.01
Change from 52-week high	-82.31%
Change from 52-week low	5.71%
Change from all-time high	-100%
Change from all-time low	4.43%
Change from open	-0.25%
Day's gap	-0.82%
Dollar volume	$162,990
High price	$0.87
Low price	$0.84
Monthly RSI	36.59
Open price	$0.87
Position in 52-week range	92.41%
Premarket change	-0.71%
Premarket close	$0.88
Premarket price	$0.87
Premarket volume	10.2K
Previous close	$0.88
Price vs 150-day SMA	-55.16%
Price vs 20-day SMA	-21.7%
Price vs 200-day SMA	-61.71%
Price vs 50-day SMA	-35.41%
Relative volume	1.64
RSI	30.65
Sharpe ratio	-2.4
Sharpe ratio (3Y)	0.11
Sharpe ratio (5Y)	-0.23
Sortino ratio	-2.96
Sortino ratio (3Y)	0.32
Sortino ratio (5Y)	-0.46
Volume	188K
Weekly RSI	27.68
YTD price change	-77.25%
YTD total return	-77.25%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.2M
Float percentage	93.55%
Shares change (QoQ)	4.05%
Shares change (YoY)	217.32%
Shares held by insiders	6.45%
Shares held by institutions	5.68%
Shares outstanding	5.6M
Short % of float	1.19%
Short % of shares	1.11%
Short ratio	1.2 days

Deeper analysis on IMNN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this IMNN report

Is a complete IMNN research report available?

No complete published report is available for Imunon, Inc. (IMNN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Imunon, Inc. (IMNN)

Price

Financial snapshot

Fair-value bridge

Latest news · IMNN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IMNN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IMNN

Frequently asked questions